CV Sciences, Inc.
CVSI
$0.03
$0.00196.76%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.71M | 15.62M | 15.85M | 15.86M | 16.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.71M | 15.62M | 15.85M | 15.86M | 16.00M |
| Cost of Revenue | 8.54M | 8.39M | 8.55M | 8.70M | 8.92M |
| Gross Profit | 7.17M | 7.23M | 7.30M | 7.16M | 7.09M |
| SG&A Expenses | 8.42M | 8.70M | 8.93M | 9.48M | 9.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 0.00 | 0.00 | 0.00 | -6.17M |
| Total Operating Expenses | 17.07M | 17.22M | 17.62M | 18.33M | 12.09M |
| Operating Income | -1.37M | -1.60M | -1.78M | -2.47M | 3.91M |
| Income Before Tax | -2.40M | -2.54M | -2.53M | -3.23M | 3.10M |
| Income Tax Expenses | -8.00K | -3.00K | -3.00K | 0.00 | -6.00K |
| Earnings from Continuing Operations | -2.39 | -2.54 | -2.53 | -3.23 | 3.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.39M | -2.54M | -2.53M | -3.23M | 3.10M |
| EBIT | -1.37M | -1.60M | -1.78M | -2.47M | 3.91M |
| EBITDA | -1.03M | -1.32M | -1.52M | -2.23M | 4.15M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.02 | 0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.02 | 0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.02 |
| Average Basic Shares Outstanding | 702.08M | 674.23M | 646.58M | 626.76M | 615.79M |
| Average Diluted Shares Outstanding | 702.08M | 674.23M | 646.58M | 626.76M | 615.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |